LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 4893 | 6928 | 0.7062 | 0.9145 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 1 | 6928 | 0.0001 | -0.3412 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.55 | 27.76 | 5388 | 6928 | 0.7776 | 0.9378 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 4085 | 6873 | 0.5943 | 0.8733 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 4154 | 6873 | 0.6044 | 0.8773 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 3279 | 6873 | 0.4771 | 0.8223 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 4990 | 6873 | 0.7260 | 0.9211 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 1 | 6873 | 0.0001 | -0.3416 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.25 | 27.76 | 5435 | 6873 | 0.7907 | 0.9418 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 4144 | 6849 | 0.6051 | 0.8775 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 4221 | 6849 | 0.6163 | 0.8818 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 3282 | 6849 | 0.4792 | 0.8232 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 5072 | 6849 | 0.7405 | 0.9258 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 93.96 | 27.76 | 5434 | 6849 | 0.7934 | 0.9426 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 4214 | 6712 | 0.6278 | 0.8858 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 4314 | 6712 | 0.6427 | 0.8914 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 2902 | 6712 | 0.4323 | 0.7990 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 5161 | 6712 | 0.7689 | 0.9347 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 1 | 6712 | 0.0001 | -0.3428 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 95.66 | 27.76 | 5478 | 6712 | 0.8161 | 0.9493 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 1.95 | 27.76 | 494 | 225 | 2.1942 | 1.5944 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 1.95 | 27.76 | 569 | 225 | 2.5273 | 1.7187 | MN20160318_Q01 | L15 |